CIK 0001099800 · Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364316614
- Phone
- 9492502500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-09 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −7,700 | 39,000 | ||
| 2025-12-08 | Zovighian Bernard J CEO | Option exercise 10b5-1 | +25,350 | $59.26 | $1.5M | 106,326 |
| 2025-12-08 | Zovighian Bernard J CEO | Sale 10b5-1 | −21,487 | $85.21 | $1.8M | 84,839 |
| 2025-12-08 | Zovighian Bernard J CEO | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −25,350 | 25,350 | ||
| 2025-12-08 | Markowitz Wayne CVP, JAPAC | Sale | −583 | $86.01 | $50K | 17,562.87 |
| 2025-11-13 | Dahl Andrew M. SVP, Corporate Controller | Grant or award | +1,160 | 9,183.07 | ||
| 2025-11-10 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +13,000 | $59.26 | $770K | 52,898 |
| 2025-11-10 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −2,974 | $83.30 | $248K | 49,924 |
| 2025-11-10 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −10,026 | $83.02 | $832K | 39,898 |
| 2025-11-10 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −13,000 | 46,700 | ||
| 2025-11-10 | Lippis Daniel J. CVP, JAPAC | Option exercise 10b5-1 | +1,020 | $59.26 | $60K | 23,021.91 |
| 2025-11-10 | Lippis Daniel J. CVP, JAPAC | Sale 10b5-1 | −1,020 | $82.55 | $84K | 22,001.91 |
| 2025-11-10 | Lippis Daniel J. CVP, JAPAC | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −1,020 | 6,114 | ||
| 2025-09-14 | Markowitz Wayne CVP, JAPAC | Shares withheld for taxes | −650 | $77.57 | $50K | 18,145.87 |
| 2025-09-13 | Dahl Andrew M. SVP, Corporate Controller | Shares withheld for taxes | −262 | $77.57 | $20K | 7,926.93 |
| 2025-09-11 | Chopra Daveen CVP, TMTT & Surgical | Grant or award | +3,205 | 34,201 | ||
| 2025-09-11 | Markowitz Wayne CVP, JAPAC | Grant or award | +6,410 | 18,795.87 | ||
| 2025-08-25 | Chopra Daveen CVP, TMTT | Sale | −2,500 | $81.95 | $205K | 30,996 |
| 2025-08-18 | Wood Larry L Global President TAVR & Surg | Option exercise 10b5-1 | +8,950 | $59.26 | $530K | 215,850.39 |
| 2025-08-18 | Wood Larry L Global President TAVR & Surg | Sale 10b5-1 | −8,950 | $78.06 | $699K | 206,900.39 |
Page 11 of 13 · 249 trades